The most recent example I can think of is Denmark, where the sales of specifically ozempic through Novo Nordisk contributed so much to Denmark’s GDP growth that without those sales Denmark would have been in recession for 2023.
Nearly 1 out of every 5 Danish jobs created last year was at Novo. And that’s just directly. If you also include the jobs that Novo has created indirectly — like, for example, at its suppliers, or from all the newly wealthy Novo employees spending their money at shops and restaurants — nearly half of all private-sector nonfarm jobs created in Denmark can be traced back to Novo. More than that, Denmark’s gross domestic product would have shrunk last year without the contribution of the pharma sector. In other words, the company has almost single-handedly rescued the country from a recession.
The most recent example I can think of is Denmark, where the sales of specifically ozempic through Novo Nordisk contributed so much to Denmark’s GDP growth that without those sales Denmark would have been in recession for 2023.
Per https://www.npr.org/sections/planet-money/2024/07/26/g-s1-13534/ozempic-biggest-side-effect-denmark-pharmastate
1 out of 5… they wanna be Lumon industries so bad